日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

更正:卡博替尼在接受常规治疗的转移性肾细胞癌患者中的暴露-反应关系

Blanchet, Benoit; Xu-Vuillard, Alexandre; Jouinot, Anne; Puisset, Florent; Combarel, David; Huillard, Olivier; Le Louedec, Félicien; Thomas, Fabienne; Teixeira, Marcus; Flippot, Ronan; Mourey, Loic; Albiges, Laurence; Pudlarz, Thomas; Joly, Charlotte; Tournigand, Christophe; Chauvin, Jonathan; Puszkiel, Alicja; Chatelut, Etienne; Decleves, Xavier; Vidal, Michel; Goldwasser, François; Oudard, Stéphane; Medioni, Jacques; Vano, Yann-Alexandre

A population pharmacokinetic approach to compare (51)Cr-EDTA and (99 m)Tc-DTPA clearances in measuring renal glomerular filtration rate in oncopediatrics

采用群体药代动力学方法比较(51)Cr-EDTA 和(99m)Tc-DTPA 清除率在肿瘤儿科肾小球滤过率测量中的应用

Gracia, Matthieu; Ankaoua, Victoire; Alonso, Mathieu; Pasquet, Marlène; Chatelut, Etienne

Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid

撤稿声明:关于使用亚叶酸逆转高剂量甲氨蝶呤细胞毒性的新建议

Heldrup, Jesper; Bleyer, Archie; Ramsey, Laura; Schaff, Lauren; Bernhardt, Brooke; Schwartz, Stefan; Chatelut, Etienne; Hwang, Miriam; Ten, Carolina; Guscott, Martin; Howard, Scott

New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid

使用亚叶酸逆转高剂量甲氨蝶呤细胞毒性的新建议

Heldrup, Jesper; Bleyer, Archie; Ramsey, Laura; Schaff, Lauren; Bernhardt, Brooke; Schwartz, Stefan; Chatelut, Etienne; Hwang, Miriam; Ten, Carolina; Guscott, Martin; Howard, Scott

Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care

卡博替尼在接受常规治疗的转移性肾细胞癌患者中的暴露-反应关系

Blanchet, Benoit; Xu-Vuillard, Alexandre; Jouinot, Anne; Puisset, Florent; Combarel, David; Huillard, Olivier; Le Louedec, Félicien; Thomas, Fabienne; Teixeira, Marcus; Flippot, Ronan; Mourey, Loic; Albiges, Laurence; Pudlarz, Thomas; Joly, Charlotte; Tournigand, Christophe; Chauvin, Jonathan; Puszkiel, Alicja; Chatelut, Etienne; Decleves, Xavier; Vidal, Michel; Goldwasser, François; Oudard, Stéphane; Medioni, Jacques; Vano, Yann-Alexandre

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

虽然并非适应症用药,但正中靶点:实施抗癌药物替代给药方案所需的证据

Overbeek, J K; Ter Heine, R; Verheul, H M W; Chatelut, E; Rudek, M A; Gurney, H; Plummer, R; Gilbert, D C; Buclin, T; Burger, D M; Bloemendal, H J; van Erp, N P

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer

酪氨酸激酶抑制剂在晚期肾癌治疗中的治疗药物监测

Puisset, Florent; Mseddi, Mourad; Mourey, Loïc; Pouessel, Damien; Blanchet, Benoit; Chatelut, Etienne; Chevreau, Christine

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer

卵巢癌患者腹腔内化疗后全身暴露于顺铂和紫杉醇

de Jong, Loek A W; Lambert, Marie; van Erp, Nielka P; de Vries, Lukas; Chatelut, Etienne; Ottevanger, Petronella B

Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury

帕唑帕尼和舒尼替尼醛衍生物在药物性肝损伤中的生物学作用

Maillard, Maud; Arellano, Cécile; Vachoux, Christelle; Chevreau, Christine; Cabaton, Nicolas J; Pont, Frédéric; Saint-Laurent, Nathalie; Lafont, Thierry; Chatelut, Etienne; Thomas, Fabienne

Correction to: Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin‑based HIPEC: results of the GUTOX study

更正:基于奥沙利铂的HIPEC术后组织、全身和引流液暴露量存在显著差异:GUTOX研究结果

de Jong, Loek A W; Elekonawo, Fortuné M K; Lambert, Marie; de Gooyer, Jan Marie; Verheul, Henk M W; Burger, David M; de Wilt, Johannes H W; Chatelut, Etienne; Ter Heine, Rob; de Reuver, Philip R; Bremers, Andre J A; van Erp, Nielka P